Mapping the Road Forward in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Mapping the Road Forward in Alzheimer’s Disease

Published:2011-12-21 Issue:114 Volume:3 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Holtzman David M.¹²³,Goate Alison⁴²³,Kelly Jeffrey⁵,Sperling Reisa⁶

Affiliation:

1. Department of Neurology, Washington University, St. Louis, MO 63110, USA.

2. Hope Center for Neurological Disorders, Washington University, St. Louis, MO 63110, USA.

3. Knight Alzheimer’s Disease Research Center, Washington University, St. Louis, MO 63110, USA.

4. Department of Psychiatry, Washington University, St. Louis, MO 63110, USA.

5. Departments of Chemistry and Molecular and Experimental Medicine and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

6. Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02446, USA.

Abstract

A better understanding of genetics, protein aggregation, and neurobiology combined with improved clinical trial design is needed to combat Alzheimer’s disease.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference21 articles.

1. Alzheimer’s Disease: The Challenge of the Second Century

2. The Genetics of Alzheimer Disease: Back to the Future

3. The Role of Apolipoprotein E in Alzheimer's Disease

4. Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE

5. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics analysis reveals GAPDH posttranscriptional regulation of IFN-γ and PHGDH as a metabolic checkpoint of microglia polarization;Brain, Behavior, and Immunity;2024-03

2. Reduced slow-wave activity and autonomic dysfunction during sleep precede cognitive deficits in Alzheimer’s disease transgenic mice;Scientific Reports;2023-07-11

3. The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells;Biomolecules;2023-02-07

4. Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II;Frontiers in Aging Neuroscience;2023-02-03

5. Identification of novel regulators involved in AD pathogenesis using the CRISPR-Cas9 system;Folia Pharmacologica Japonica;2023